Influenza virus DNA vaccine (PowderMed)

N/A

Report date: 2022/11/25 17:43:07

Base Information

Drug NameInfluenza virus DNA vaccine (PowderMed)

Drug Alias NameInfluenza virus vaccine-PowderMedPF-4522625

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPowdermed Ltd

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A